These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21795425)

  • 1. Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers.
    Cheng TY; Barnett MJ; Kristal AR; Ambrosone CB; King IB; Thornquist MD; Goodman GE; Neuhouser ML
    J Nutr; 2011 Sep; 141(9):1731-7. PubMed ID: 21795425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial.
    Cheng TY; King IB; Barnett MJ; Ambrosone CB; Thornquist MD; Goodman GE; Neuhouser ML
    Am J Epidemiol; 2013 May; 177(10):1106-17. PubMed ID: 23535901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
    Weinstein SJ; Peters U; Ahn J; Friesen MD; Riboli E; Hayes RB; Albanes D
    PLoS One; 2012; 7(7):e40204. PubMed ID: 22792240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
    Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
    BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort.
    Choi JY; Neuhouser ML; Barnett MJ; Hong CC; Kristal AR; Thornquist MD; King IB; Goodman GE; Ambrosone CB
    Carcinogenesis; 2008 May; 29(5):964-70. PubMed ID: 18296681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
    Bauer SR; Richman EL; Sosa E; Weinberg V; Song X; Witte JS; Carroll PR; Chan JM
    Prostate; 2013 Dec; 73(16):1786-95. PubMed ID: 24038157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
    Key TJ; Appleby PN; Travis RC; Albanes D; Alberg AJ; Barricarte A; Black A; Boeing H; Bueno-de-Mesquita HB; Chan JM; Chen C; Cook MB; Donovan JL; Galan P; Gilbert R; Giles GG; Giovannucci E; Goodman GE; Goodman PJ; Gunter MJ; Hamdy FC; Heliövaara M; Helzlsouer KJ; Henderson BE; Hercberg S; Hoffman-Bolton J; Hoover RN; Johansson M; Khaw KT; King IB; Knekt P; Kolonel LN; Le Marchand L; Männistö S; Martin RM; Meyer HE; Mondul AM; Moy KA; Neal DE; Neuhouser ML; Palli D; Platz EA; Pouchieu C; Rissanen H; Schenk JM; Severi G; Stampfer MJ; Tjønneland A; Touvier M; Trichopoulou A; Weinstein SJ; Ziegler RG; Zhou CK; Allen NE;
    Am J Clin Nutr; 2015 Nov; 102(5):1142-57. PubMed ID: 26447150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
    Weinstein SJ; Wright ME; Pietinen P; King I; Tan C; Taylor PR; Virtamo J; Albanes D
    J Natl Cancer Inst; 2005 Mar; 97(5):396-9. PubMed ID: 15741576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
    Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
    Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
    Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).
    Woodson K; Tangrea JA; Lehman TA; Modali R; Taylor KM; Snyder K; Taylor PR; Virtamo J; Albanes D
    Cancer Causes Control; 2003 Aug; 14(6):513-8. PubMed ID: 12948282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.
    Watters JL; Gail MH; Weinstein SJ; Virtamo J; Albanes D
    Cancer Res; 2009 May; 69(9):3833-41. PubMed ID: 19383902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk.
    Mondul AM; Rohrmann S; Menke A; Feinleib M; Nelson WG; Platz EA; Albanes D
    Cancer Causes Control; 2011 Jun; 22(6):827-36. PubMed ID: 21424597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers.
    Stolzenberg-Solomon RZ; Sheffler-Collins S; Weinstein S; Garabrant DH; Mannisto S; Taylor P; Virtamo J; Albanes D
    Am J Clin Nutr; 2009 Feb; 89(2):584-91. PubMed ID: 19116326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk.
    Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Wu K; Erdman JW; Giovannucci E
    Carcinogenesis; 2008 Dec; 29(12):2335-40. PubMed ID: 18784358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and dietary vitamin E in relation to prostate cancer risk.
    Weinstein SJ; Wright ME; Lawson KA; Snyder K; Männistö S; Taylor PR; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1253-9. PubMed ID: 17548693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
    Arslan S; Pinarbasi H; Silig Y
    Mol Med Rep; 2011; 4(1):87-92. PubMed ID: 21461569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
    Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood α-tocopherol, γ-tocopherol levels and risk of prostate cancer: a meta-analysis of prospective studies.
    Cui R; Liu ZQ; Xu Q
    PLoS One; 2014; 9(3):e93044. PubMed ID: 24667740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.